Author:
Deng C,Zhang B,Zhang S,Duan C,Cao Y,Kang W,Yan H,Ding X,Zhou F,Wu L,Duan G,Shen S,Xu G,Zhang W,Chen M,Huang S,Zhang X,Lv Y,Ling T,Wang L,Zou X
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference42 articles.
1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A . Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87–108.
2. Wadhwa R, Song S, Lee JS, Yao Y, Wei Q, Ajani JA . Gastric cancer-molecular and clinical dimensions. Nat Rev Clin Oncol 2013; 10: 643–655.
3. Lordick F, Kang YK, Chung HC, Salman P, Oh SC, Bodoky G et al. Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial. Lancet Oncol 2013; 14: 490–499.
4. Blaskovich MA, Sun J, Cantor A, Turkson J, Jove R, Sebti SM . Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res 2003; 63: 1270–1279.
5. Lui VW, Yau DM, Wong EY, Ng YK, Lau CP, Ho Y et al. Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells. Carcinogenesis 2009; 30: 2085–2094.
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献